Published in Blood on March 15, 1998
Molecular pathways in virus-induced cytokine production. Microbiol Mol Biol Rev (2001) 1.97
Dual-promoter lentiviral system allows inducible expression of noxious proteins in macrophages. J Immunol Methods (2007) 1.36
Requirements for the induction of interleukin-6 by herpes simplex virus-infected leukocytes. J Virol (2001) 1.17
The expression of exogenous genes in macrophages: obstacles and opportunities. Methods Mol Biol (2009) 1.05
Cdc42 and RhoB activation are required for mannose receptor-mediated phagocytosis by human alveolar macrophages. Mol Biol Cell (2004) 1.00
HIV-1 Tat mediates degradation of RON receptor tyrosine kinase, a regulator of inflammation. J Immunol (2008) 0.85
Evaluation of transduction efficiency in macrophage colony-stimulating factor differentiated human macrophages using HIV-1 based lentiviral vectors. BMC Biotechnol (2011) 0.83
Induction of CC-chemokines with antiviral function in macrophages by the human T lymphotropic virus type 2 transactivating protein, Tax2. Viral Immunol (2013) 0.81
HIV-1 infection of T cells and macrophages are differentially modulated by virion-associated Hck: a Nef-dependent phenomenon. Viruses (2013) 0.77
HTLV-III infection in brains of children and adults with AIDS encephalopathy. Science (1985) 7.70
Characterization and chromosomal localization of a cDNA encoding brain amyloid of Alzheimer's disease. Science (1987) 6.89
Human immunodeficiency virus type 1 neutralization epitope with conserved architecture elicits early type-specific antibodies in experimentally infected chimpanzees. Proc Natl Acad Sci U S A (1988) 6.74
Unconventional viruses and the origin and disappearance of kuru. Science (1977) 6.38
Creutzfeldt-Jakob disease (spongiform encephalopathy): transmission to the chimpanzee. Science (1968) 5.76
Creutzfeldt-Jakob disease: patterns of worldwide occurrence and the significance of familial and sporadic clustering. Ann Neurol (1979) 5.53
Human spongiform encephalopathy: the National Institutes of Health series of 300 cases of experimentally transmitted disease. Ann Neurol (1994) 5.20
The 14-3-3 brain protein in cerebrospinal fluid as a marker for transmissible spongiform encephalopathies. N Engl J Med (1996) 5.06
Experimental transmission of a Kuru-like syndrome to chimpanzees. Nature (1966) 4.29
Creutzfeldt-Jakob disease and related transmissible spongiform encephalopathies. N Engl J Med (1998) 3.62
Danger of accidental person-to-person transmission of Creutzfeldt-Jakob disease by surgery. Lancet (1977) 3.58
Localization of amyloid beta protein messenger RNA in brains from patients with Alzheimer's disease. Science (1987) 3.07
Real and imagined clinicopathological limits of "prion dementia". Lancet (1993) 2.96
Transmission and passage of experimenal "kuru" to chimpanzees. Science (1967) 2.64
Conformational transitions, dissociation, and unfolding of scrapie amyloid (prion) protein. J Biol Chem (1993) 2.59
Detection of flaviviruses by reverse-transcriptase polymerase chain reaction. J Med Virol (1991) 2.59
Transmissible familial Creutzfeldt-Jakob disease associated with five, seven, and eight extra octapeptide coding repeats in the PRNP gene. Proc Natl Acad Sci U S A (1991) 2.55
The foamy viruses. Bacteriol Rev (1975) 2.53
Interleukin 1 regulates synthesis of amyloid beta-protein precursor mRNA in human endothelial cells. Proc Natl Acad Sci U S A (1989) 2.48
The epidemiology of Creutzfeldt-Jakob disease: conclusion of a 15-year investigation in France and review of the world literature. Neurology (1987) 2.46
Identification of Mycobacterium tuberculosis by polymerase chain reaction. Lancet (1990) 2.39
Experimental infection with Puumala virus, the etiologic agent of nephropathia epidemica, in bank voles (Clethrionomys glareolus). J Virol (1985) 2.39
Infection of chimpanzees by human T-lymphotropic retroviruses in brain and other tissues from AIDS patients. Lancet (1985) 2.35
Infection-specific particle from the unconventional slow virus diseases. Science (1984) 2.34
Persistent infection of chimpanzees with human immunodeficiency virus: serological responses and properties of reisolated viruses. J Virol (1987) 2.28
The new biology of spongiform encephalopathy: infectious amyloidoses with a genetic twist. Lancet (1991) 2.16
A modified polyriboinosinic-polyribocytidylic acid complex that induces interferon in primates. J Infect Dis (1975) 2.14
Precautions in medical care of, and in handling materials from, patients with transmissible virus dementia (Creutzfeldt-Jakob disease). N Engl J Med (1977) 2.10
Clinical and pathological features and laboratory confirmation of Creutzfeldt-Jakob disease in a recipient of pituitary-derived human growth hormone. N Engl J Med (1985) 2.09
Evidence for widespread infection of wild rats with hepatitis E virus in the United States. Am J Trop Med Hyg (1999) 2.08
Predominace of a novel Mycobacterium tuberculosis genotype in the Delhi region of India. Tuberculosis (Edinb) (2002) 2.08
HTLV-I and HTLV-III antibodies and tropical spastic paraparesis. Lancet (1985) 2.07
The first major outbreak of dengue hemorrhagic fever in Delhi, India. Emerg Infect Dis (1999) 2.07
Creutzfeldt-Jakob disease: clinical analysis of a consecutive series of 230 neuropathologically verified cases. Ann Neurol (1986) 2.06
Diagnosis of Creutzfeldt-Jakob disease by Western blot identification of marker protein in human brain tissue. N Engl J Med (1986) 2.06
Survival of scrapie virus after 3 years' interment. Lancet (1991) 1.99
Oral transmission of kuru, Creutzfeldt-Jakob disease, and scrapie to nonhuman primates. J Infect Dis (1980) 1.96
Creutzfeldt-Jakob disease. The neuropathology of a transmission experiment. Brain (1969) 1.96
New paradigm for lymphocyte granule-mediated cytotoxicity. Target cells bind and internalize granzyme B, but an endosomolytic agent is necessary for cytosolic delivery and subsequent apoptosis. J Biol Chem (1996) 1.94
Paratyphoid fever in India: An emerging problem. Emerg Infect Dis (1999) 1.89
HIN-1, a putative cytokine highly expressed in normal but not cancerous mammary epithelial cells. Proc Natl Acad Sci U S A (2001) 1.89
Serotypic classification of hantaviruses by indirect immunofluorescent antibody and plaque reduction neutralization tests. J Clin Microbiol (1985) 1.87
Different patterns of truncated prion protein fragments correlate with distinct phenotypes in P102L Gerstmann-Sträussler-Scheinker disease. Proc Natl Acad Sci U S A (1998) 1.85
Infection as the etiology of spongiform encephalopathy (Creutzfeldt-Jakob disease). Science (1969) 1.83
Slow virus diseases of the central nervous system. Am J Clin Pathol (1971) 1.83
Subacute spongiform virus encephalopathies. Scrapie, Kuru and Creutzfeldt-Jakob disease: a review. Am J Pathol (1972) 1.81
The familial occurrence of Creutzfeldt-Jakob disease and Alzheimer's disease. Brain (1981) 1.80
Natural and experimental oral infection of nonhuman primates by bovine spongiform encephalopathy agents. Proc Natl Acad Sci U S A (1999) 1.80
Phenotypic variability of Gerstmann-Sträussler-Scheinker disease is associated with prion protein heterogeneity. J Neuropathol Exp Neurol (1998) 1.79
Antigenic differences between isolates of herpesvirus type 2. Intervirology (1974) 1.79
The distribution of infectivity in blood components and plasma derivatives in experimental models of transmissible spongiform encephalopathy. Transfusion (1998) 1.78
Evidence that the penton base of adenovirus is involved in potentiation of toxicity of Pseudomonas exotoxin conjugated to epidermal growth factor. Mol Cell Biol (1984) 1.76
Seroepidemiology of human papovaviruses. Discovery of virgin populations and some unusual patterns of antibody prevalence among remote peoples of the world. Am J Epidemiol (1975) 1.76
Potential epidemic of Creutzfeldt-Jakob disease from human growth hormone therapy. N Engl J Med (1985) 1.75
pH-dependent lysis of liposomes by adenovirus. Biochemistry (1986) 1.74
Hypothesis: interference with axonal transport of neurofilament as a common pathogenetic mechanism in certain diseases of the central nervous system. N Engl J Med (1985) 1.73
Experimental subacute spongiform virus encephalopathies in primates and other laboratory animals. Science (1973) 1.71
p21(Waf1/Cip1) protects against p53-mediated apoptosis of human melanoma cells. Oncogene (1997) 1.70
Beta amyloid gene duplication in Alzheimer's disease and karyotypically normal Down syndrome. Science (1987) 1.67
Imaging of calcium and aluminum in neurofibrillary tangle-bearing neurons in parkinsonism-dementia of Guam. Proc Natl Acad Sci U S A (1984) 1.66
Syndromes of amyotrophic lateral sclerosis and dementia: relation to transmissible Creutzfeldt-Jakob disease. Ann Neurol (1983) 1.65
Latent viruses in chimpanzees with experimental kuru. Nature (1967) 1.64
p53 regulates the expression of the tumor suppressor gene maspin. J Biol Chem (2000) 1.64
Intraneuronal aluminum accumulation in amyotrophic lateral sclerosis and Parkinsonism-dementia of Guam. Science (1982) 1.63
The clinical characteristics of transmissible Creutzfeldt-Jakob disease. Brain (1973) 1.62
Adenovirus-dependent release of 51Cr from KB cells at an acidic pH. J Biol Chem (1984) 1.62
[Creutzfeldt Jakob disease. Recommended precautions for patient management and diagnostic procedures (author's transl)]. Rev Neurol (Paris) (1978) 1.61
Characterization of four new adenovirus serotypes isolated from chimpanzee tissue explants. Am J Epidemiol (1971) 1.61